Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
The chronic phase of HIV infection is marked by pathological activation of the immune system, the extent of which better predicts disease progression than either plasma viral load or CD4+ T cell count. Recently, translocation of microbial products from the gastrointestinal tract has been proposed as an underlying cause of this immune activation, based on indirect evidence including the detection of microbial products and specific immune responses in the plasma of chronically HIV-infected humans or SIV-infected Asian macaques. We analyzed tissues from SIV-infected rhesus macaques (RMs) to provide direct in situ evidence for translocation of microbial constituents from the lumen of the intestine into the lamina propria and to draining and peripheral lymph nodes and liver, accompanied by local immune responses in affected tissues. In chronically SIV-infected RMs this translocation is associated with breakdown of the integrity of the epithelial barrier of the gastrointestinal (GI) tract and apparent inability of lamina propria macrophages to effectively phagocytose translocated microbial constituents. By contrast, in the chronic phase of SIV infection in sooty mangabeys, we found no evidence of epithelial barrier breakdown, no increased microbial translocation and no pathological immune activation. Because immune activation is characteristic of the chronic phase of progressive HIV/SIV infections, these findings suggest that increased microbial translocation from the GI tract, in excess of capacity to clear the translocated microbial constituents, helps drive pathological immune activation. Novel therapeutic approaches to inhibit microbial translocation and/or attenuate chronic immune activation in HIV-infected individuals may complement treatments aimed at direct suppression of viral replication.
Vyšlo v časopise:
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001052
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001052
Souhrn
The chronic phase of HIV infection is marked by pathological activation of the immune system, the extent of which better predicts disease progression than either plasma viral load or CD4+ T cell count. Recently, translocation of microbial products from the gastrointestinal tract has been proposed as an underlying cause of this immune activation, based on indirect evidence including the detection of microbial products and specific immune responses in the plasma of chronically HIV-infected humans or SIV-infected Asian macaques. We analyzed tissues from SIV-infected rhesus macaques (RMs) to provide direct in situ evidence for translocation of microbial constituents from the lumen of the intestine into the lamina propria and to draining and peripheral lymph nodes and liver, accompanied by local immune responses in affected tissues. In chronically SIV-infected RMs this translocation is associated with breakdown of the integrity of the epithelial barrier of the gastrointestinal (GI) tract and apparent inability of lamina propria macrophages to effectively phagocytose translocated microbial constituents. By contrast, in the chronic phase of SIV infection in sooty mangabeys, we found no evidence of epithelial barrier breakdown, no increased microbial translocation and no pathological immune activation. Because immune activation is characteristic of the chronic phase of progressive HIV/SIV infections, these findings suggest that increased microbial translocation from the GI tract, in excess of capacity to clear the translocated microbial constituents, helps drive pathological immune activation. Novel therapeutic approaches to inhibit microbial translocation and/or attenuate chronic immune activation in HIV-infected individuals may complement treatments aimed at direct suppression of viral replication.
Zdroje
1. LaneHC
1984 Polyclonal activation of B cells in homosexual men. New Engl J Med 31 536 537
2. HellersteinM
HanleyMB
CesarD
SilerS
PapageorgopoulosC
1999 Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5 83 89
3. HazenbergMD
OttoSA
van BenthemBH
RoosMT
CoutinhoRA
2003 Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Aids 17 1881 1888
4. ValdezH
LedermanMM
1997 Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 187 228
5. GiorgiJV
HultinLE
McKeatingJA
JohnsonTD
OwensB
1999 Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179 859 870
6. SilvestriG
SodoraDL
KoupRA
PaiardiniM
O'NeilSP
2003 Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18 441 452
7. BrenchleyJM
PriceDA
DouekDC
2006 HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7 235 239
8. GrossmanZ
Meier-SchellersheimM
PaulWE
PickerLJ
2006 Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 12 289 295
9. BrenchleyJM
PriceDA
SchackerTW
AsherTE
SilvestriG
2006 Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12 1365 1371
10. MarchettiG
BellistriGM
BorghiE
TincatiC
FerramoscaS
2008 Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22 2035 2038
11. AncutaP
KamatA
KunstmanKJ
KimEY
AutissierP
2008 Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3 e2516
12. AnselmiA
VendrameD
RamponO
GiaquintoC
ZanchettaM
2007 Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy. Clin Exp Immunol 150 442 450
13. BalagopalA
PhilpFH
AstemborskiJ
BlockTM
MehtaA
2008 Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C. Gastroenterology
14. JiangW
LedermanMM
HuntP
SiegSF
HaleyK
2009 Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection. J Infect Dis 199 1177 1185
15. CookeKR
OlkiewiczK
EricksonN
FerraraJL
2002 The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 8 441 448
16. BaystonK
BaumgartnerJD
ClarkP
CohenJ
1991 Anti-endotoxin antibody for prevention of acute GVHD. Bone Marrow Transplant 8 426 427
17. LangrehrJM
MachensC
ZillE
LederK
NusslerA
2000 Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis. Transplantation 69 2415 2421
18. CookeKR
GerbitzA
CrawfordJM
TeshimaT
HillGR
2001 LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 107 1581 1589
19. CaradonnaL
AmatiL
MagroneT
PellegrinoNM
JirilloE
2000 Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6 205 214
20. SchietromaM
CarleiF
CappelliS
AmicucciG
2006 Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann Surg 243 359 363
21. SchietromaM
CarleiF
CappelliS
PescosolidoA
LygidakisNJ
2007 Effects of cholecystectomy (laparoscopic versus open) on PMN-elastase. Hepatogastroenterology 54 342 345
22. AmmoriBJ
FitzgeraldP
HawkeyP
McMahonMJ
2003 The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas 26 18 22
23. LiQ
EstesJD
DuanL
JessurunJ
PambuccianS
2008 Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis 197 420 429
24. VeazeyRS
DeMariaM
ChalifouxLV
ShvetzDE
PauleyDR
1998 Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 427 431
25. CecchinatoV
TrindadeC
LaurenceA
HeraudJ
BrenchleyJ
2008 Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficienty virus-infected macaques. Mucosal Immunology 1 279 288
26. BrenchleyJM
PaiardiniM
KnoxKS
AsherAI
CervasiB
2008 Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112 2826 2835
27. SchackerTW
NguyenPL
BeilmanGJ
WolinskyS
LarsonM
2002 Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 110 1133 1139
28. NakanishiK
YoshimotoT
TsutsuiH
OkamuraH
2001 Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19 423 474
29. AhmadR
SindhuST
TomaE
MorissetR
AhmadA
2002 Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis. J Virol 76 12448 12456
30. GroismanGM
AmarM
LivneE
2002 CD10: a valuable tool for the light microscopic diagnosis of microvillous inclusion disease (familial microvillous atrophy). Am J Surg Pathol 26 902 907
31. SankaranS
GuadalupeM
ReayE
GeorgeMD
FlammJ
2005 Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci U S A 102 9860 9865
32. KotlerDP
GaetzHP
LangeM
KleinEB
HoltPR
1984 Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 101 421 428
33. KapembwaMS
FlemingSC
SewankamboN
SerwaddaD
LucasS
1991 Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci (Lond) 81 327 334
34. BjarnasonI
SharpstoneDR
FrancisN
MarkerA
TaylorC
1996 Intestinal inflammation, ileal structure and function in HIV. Aids 10 1385 1391
35. SharpstoneD
NeildP
CraneR
TaylorC
HodgsonC
1999 Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut 45 70 76
36. BatmanPA
MillerAR
ForsterSM
HarrisJR
PinchingAJ
1989 Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol 42 275 281
37. HeiseC
MillerCJ
LacknerA
DandekarS
1994 Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis 169 1116 1120
38. BatmanPA
KotlerDP
KapembwaMS
BoothD
PottenCS
2007 HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia-infected jejunal mucosa. Aids 21 433 439
39. EstesJ
BakerJV
BrenchleyJM
KhorutsA
BartholdJL
2008 Collagen deposition limits immune reconstitution in the gut. J Infect Dis 198 456 464
40. SmythiesLE
SellersM
ClementsRH
Mosteller-BarnumM
MengG
2005 Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115 66 75
41. PandreaI
ApetreiC
DufourJ
DillonN
BarbercheckJ
2006 Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts. J Virol 80 4858 4867
42. ChakrabartiLA
LewinSR
ZhangL
GettieA
LuckayA
2000 Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol 74 1209 1223
43. SumpterB
DunhamR
GordonS
EngramJ
HennessyM
2007 Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J Immunol 178 1680 1691
44. PandreaI
OnangaR
KornfeldC
RouquetP
BourryO
2003 High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx. Virology 317 119 127
45. PandreaIV
GautamR
RibeiroRM
BrenchleyJM
ButlerIF
2007 Acute Loss of Intestinal CD4+ T Cells Is Not Predictive of Simian Immunodeficiency Virus Virulence. J Immunol 179 3035 3046
46. GordonSN
KlattNR
BosingerSE
BrenchleyJM
MilushJM
2007 Severe Depletion of Mucosal CD4+ T Cells in AIDS-Free Simian Immunodeficiency Virus-Infected Sooty Mangabeys. J Immunol 179 3026 3034
47. EstesJD
GordonSN
ZengM
ChahroudiAM
DunhamRM
2008 Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol 180 6798 6807
48. MandlJN
BarryAP
VanderfordTH
KozyrN
ChavanR
2008 Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14 1077 1087
49. KaoCY
ChenY
ThaiP
WachiS
HuangF
2004 IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173 3482 3491
50. LiangSC
TanXY
LuxenbergDP
KarimR
Dunussi-JoannopoulosK
2006 Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 2271 2279
51. KollsJK
LindenA
2004 Interleukin-17 family members and inflammation. Immunity 21 467 476
52. FavreD
LedererS
KanwarB
MaZM
ProllS
2009 Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 5 e1000295
53. KedzierskaK
AzzamR
ElleryP
MakJ
JaworowskiA
2003 Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol 26 247 263
54. BaquiAA
Jabra-RizkMA
KelleyJI
ZhangM
FalklerWAJr
2000 Enhanced interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by LPS stimulated human monocytes isolated from HIV+ patients. Immunopharmacol Immunotoxicol 22 401 421
55. SchulbinH
BodeH
StockerH
SchmidtW
ZippelT
2008 Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy. Antimicrob Agents Chemother 52 3377 3384
56. MillerCJ
LiQ
AbelK
KimEY
MaZM
2005 Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79 9217 9227
57. ClineAN
BessJW
PiatakMJr
LifsonJD
2005 Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 34 303 312
58. LiQ
DuanL
EstesJD
MaZM
RourkeT
2005 Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 1148 1152
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia
- Dissecting the Genetic Architecture of Host–Pathogen Specificity